Geopolitics Alpha

8-K - Rapport Therapeutics, Inc. (0002012593) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Rapport Therapeutics filed an 8-K with the SEC on Oct 30 (a notice of a material company event).
  • Exposed: RAPP
  • Market reaction: RAPP −5.2% after three sessions

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHA8-K - Rapport Therapeutics, Inc.(0002012593) (Filer)RAPPGEOPOLITICS ALPHA

8-K - Rapport Therapeutics filed an 8-K with the SEC on Oct 30 (a notice of a material company event).

Directly affected

  • RAPP Rapport Therapeutics-11.9% 18d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Rapport Therapeutics belongs to, so it often moves with news about it.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and is a peer of Rapport Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson is a peer of Rapport Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABBV AbbVie+12.0% 30d

    AbbVie is a peer of Rapport Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • MRK Merck+3.5% 30d

    Merck is a peer of Rapport Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABT Abbott Laboratories+10.0% 30d

    Abbott Laboratories is a peer of Rapport Therapeutics in pharmaceutical preparations; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
RAPP+1.16%-10.15%base+0.36%+1.68%+3.58%-5.22%
XLV-3.03%-2.77%base-0.14%-0.48%+2.59%+0.17%
LLY-9.71%-8.92%base-0.37%-0.54%+0.07%-3.00%
JNJ-2.53%-0.72%base-0.98%-2.59%+1.13%-0.32%
ABBV-2.71%-2.90%base-2.03%-3.03%-0.45%-1.91%
MRK-5.94%-5.65%base-0.74%-3.26%+0.55%-1.48%
ABT-1.26%-3.36%base+3.81%+2.97%+9.08%+6.88%

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-10-30 AccNo: 0001193125-26-441851 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 2.03: Creation of a Direct Financial Obligation or an Obligation u…

Source: sec-edgar

The price since 30 Oct 2026: Rapport Therapeutics (RAPP) versus the S&P 500

Since the first closing price after “8-K - Rapport Therapeutics, Inc. (0002012593) (Filer),” Rapport Therapeutics (RAPP) is +2.89%.

CompanyWhenMoveStatus
ABBVthat day-2.03%final price
ABBVthe next day-3.03%final price
ABBVtwo days later-0.45%final price
ABBVthree days later-1.91%final price
ABBVthree days earlier-2.90%final price
ABBVfive days earlier-2.71%final price
ABTthat day+3.81%final price
ABTthe next day+2.97%final price
ABTtwo days later+9.08%final price
ABTthree days later+6.88%final price
ABTthree days earlier-3.36%final price
ABTfive days earlier-1.26%final price
JNJthat day-0.98%final price
JNJthe next day-2.59%final price
JNJtwo days later+1.13%final price
JNJthree days later-0.32%final price
JNJthree days earlier-0.72%final price
JNJfive days earlier-2.53%final price
LLYthat day-0.37%final price
LLYthe next day-0.54%final price
LLYtwo days later+0.07%final price
LLYthree days later-3.00%final price
LLYthree days earlier-8.92%final price
LLYfive days earlier-9.71%final price
MRKthat day-0.74%final price
MRKthe next day-3.26%final price
MRKtwo days later+0.55%final price
MRKthree days later-1.48%final price
MRKthree days earlier-5.65%final price
MRKfive days earlier-5.94%final price
Rapport Therapeutics (RAPP)that day+0.36%final price
Rapport Therapeutics (RAPP)the next day+1.68%final price
Rapport Therapeutics (RAPP)two days later+3.58%final price
Rapport Therapeutics (RAPP)three days later-5.22%final price
Rapport Therapeutics (RAPP)three days earlier-10.15%final price
Rapport Therapeutics (RAPP)five days earlier+1.16%final price
XLVthat day-0.14%final price
XLVthe next day-0.48%final price
XLVtwo days later+2.59%final price
XLVthree days later+0.17%final price
XLVthree days earlier-2.77%final price
XLVfive days earlier-3.03%final price
RAPP

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Rapport Therapeutics (RAPP)

Companies carried with this story

  • RAPP Rapport Therapeutics

    In “8-K - Rapport Therapeutics, Inc. (0002012593) (Filer),” Rapport Therapeutics (RAPP) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> RAPP

How “8-K - Rapport Therapeutics, Inc. (0002012593) (Filer)” reaches Rapport Therapeutics (RAPP)

Rapport Therapeutics (RAPP) is the company in “8-K - Rapport Therapeutics, Inc. (0002012593) (Filer),” the 30 Oct 2026 this story story.

What ties Rapport Therapeutics (RAPP) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> RAPP

Price levels for Rapport Therapeutics (RAPP)

RAPP traded between 22.08 and 31.26 across 18 sessions. The latest close on file is 25.82.

How strong the case is around Rapport Therapeutics (RAPP)

14 out of 100

“8-K - Rapport Therapeutics, Inc. (0002012593) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.